US Physical Therapy opened higher at $100.74, compared with its previous close of $100.10. In the last trading session, the stock traded between $97.71 and $101.80. It showed a downward intraday trend.
An investment of $100 made 5 years ago in US Physical Therapy is now worth
$ 96.65
Resulting in a loss of
$ 3.35 (3.35%)
Note: Past profits do not guarantee future returns.
Rating from 4 Analysts
Today's Change
$-1.49 (-1.49%)
Day High
$101.80
Day Low
$97.71
Day Open
$100.74
Prev Close
$100.10
Volume
1,07,205
1W Return
10.37%
1M Return
14.68%
3M Return
20.67%
6M Return
65.96%
1Y Return
32.56%
Market Cap ($ Mn)
1,472
PE Ratio
436.83
PB Ratio
2.62
PEG Ratio
2,575.67
ROE
11.76%
ROCE
8.20%
EPS (TTM)
$-1.04
1 Week
10.37%
1 Month
14.68%
3 Months
20.67%
6 Months
65.96%
9 Months
11.88%
Barrington Research lifts US Physical Therapy price target to $110
Barrington Research maintains Outperform rating on US Physical Therapy. Price target raised from $98 to $110 per share. Analyst Michael Petusky issued the rating update.
6 days agoUS Physical Therapy Q3FY26 Results: Revenue up 13%, EBITDA grows 16%
Total revenue rose 13% YoY to $223 million, driven by 8% volume growth and higher reimbursement rates. EBITDA increased 16% to $28 million, with hospital revenue jumping from <5% to >13% of total revenue. Net rate per visit hit a record high of $112 in September, up more than $5 YoY due to hospital partnerships. Full-year EBITDA guidance of $102 million to $106 million was reaffirmed despite elevated health insurance costs.
7 days agoU.S. Physical Therapy appoints Myra Davis to board effective October 2026
U.S. Physical Therapy appointed Myra Davis to its board effective October 1, 2026. Davis is currently EVP and Chief Information Innovation Officer at Texas Children’s Hospital. She brings over two decades of healthcare IT leadership experience to the board. Davis also serves on the board of Werfen, a global medical diagnostics company.
1mo agoUS Physical Therapy Q2FY26 Results: Revenue rises 8.5% to $214 million
Revenue rose 8.5% YoY to $214 million, driven by 6.6% visit growth and record net rates. Adjusted EBITDA held flat at $27.0 million as margin pressure offset by volume gains. Gross profit margin contracted to 19.9% from 21.4% due to higher healthcare claims. Company integrated 31 clinics into hospital affiliations, with 39 more expected in Q3. Full-year 2026 adjusted EBITDA guidance reaffirmed at $102 million to $106 million.
1mo agoUSPH CEO discusses healthcare outlook at Midwest Ideas Conference
Chris Reading presented at the 17th Annual Midwest Ideas Conference on August 26, 2026. Discussion covered the healthcare operating environment and key company initiatives. USPH operates 798 outpatient physical therapy locations in 45 states. The company also provides industrial injury prevention and onsite rehabilitation services.
2mo agoU.S. Physical Therapy appoints Nchacha Etta as CFO effective Sept 1
U.S. Physical Therapy Inc (NYSE: USPH) announced the appointment of Nchacha Etta as Executive Vice President and Chief Financial Officer, effective September 1, 2026. Etta succeeds Jason Curtis, who served as Interim CFO since April 24, 2026, and will remain as Senior Vice President of Finance and Accounting. Etta brings prior experience as CFO at Omnicell Inc, Essilor of America Inc, and Johnson & Johnson Vision.
3mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $506.04 | +0.32% | $1,05,708.21M | 14.01 | |
| $304.77 | -0.26% | $49,345.01M | 45.36 | |
| $292.97 | +0.93% | $23,316.90M | 10.31 | |
| $72.62 | +0.18% | $14,450.29M | 52.31 | |
| $79.43 | -1.38% | $14,087.55M | - | |
| $142.24 | -0.19% | $13,957.16M | 20.21 | |
| $22.22 | -2.29% | $11,935.03M | 11.93 | |
| $183.50 | +2.35% | $11,542.15M | 15.26 | |
| $186.19 | +0.59% | $10,862.51M | 27.11 | |
| $196.77 | +0.70% | $10,170.65M | 7.00 | |
| $103.03 | -0.49% | $8,522.13M | 34.79 | |
| $50.06 | +1.96% | $7,945.72M | 25.00 |
An investment of $100 made 5 years ago in US Physical Therapy is now worth
$ 96.65
Resulting in a loss of
$ 3.35 (3.35%)
Note: Past profits do not guarantee future returns.
